SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

ABSTRACT BACKGROUND: Patients with inflammatory bowel disease (IBD) vaccinated for hepatitis B have a low success rate in achieving protective antibody levels. The main factors suggested for this are IBD itself and the use of immunosuppressive drugs. OBJECTIVE: To evaluate the concentration of anti-HBs antibodies and to verify factors associated with the effectiveness of hepatitis B vaccination in patients with IBD. METHODS: This is a prospective, consecutive, observational, descriptive and analytical, non-randomized, qualitative study that evaluated the levels of anti-HBs antibodies in IBD patients at the Interdisciplinary Inflammatory Bowel Disease Clinic of the Family and Community Health Unit of UNIVALI - Itajaí, Santa Catarina. RESULTS: Thirty-six patients were vaccinated against hepatitis B virus (HBV), of which 29 were female. The average age was 46.2 years. Regarding the type of IBD, twenty-four patients had Crohn’s disease and the duration of inflammatory bowel disease was 74 months. Fifteen patients were on concomitant immunosuppressive therapy. The effective response rate to HBV vaccine was 72.2%, verified by anti-HBs titration ≥10 UI/L. Statistical analysis revealed a negative response to vaccination in patients with Crohn’s disease and immunosuppressive drugs. CONCLUSION: The success rate of HBV immunization in IBD patients is low compared to the general population. Type of disease and use of immunosuppressive drugs appear to influence the vaccine response.

Saved in:
Bibliographic Details
Main Authors: CUNHA,Isabella de Souza, SILVA,Tayná Cristina da, MALLUTA,Éverson Fernando, SCOLARO,Bruno Lorenzo, VELHO,Pablo Sebastian, STALL,Juliane
Format: Digital revista
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032020000100069
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-28032020000100069
record_format ojs
spelling oai:scielo:S0004-280320200001000692020-04-07SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASESCUNHA,Isabella de SouzaSILVA,Tayná Cristina daMALLUTA,Éverson FernandoSCOLARO,Bruno LorenzoVELHO,Pablo SebastianSTALL,Juliane Inflammatory bowel diseases Immunization Hepatitis B Crohn’s disease Ulcerative colitis Seroconversion Immunosuppressive agents ABSTRACT BACKGROUND: Patients with inflammatory bowel disease (IBD) vaccinated for hepatitis B have a low success rate in achieving protective antibody levels. The main factors suggested for this are IBD itself and the use of immunosuppressive drugs. OBJECTIVE: To evaluate the concentration of anti-HBs antibodies and to verify factors associated with the effectiveness of hepatitis B vaccination in patients with IBD. METHODS: This is a prospective, consecutive, observational, descriptive and analytical, non-randomized, qualitative study that evaluated the levels of anti-HBs antibodies in IBD patients at the Interdisciplinary Inflammatory Bowel Disease Clinic of the Family and Community Health Unit of UNIVALI - Itajaí, Santa Catarina. RESULTS: Thirty-six patients were vaccinated against hepatitis B virus (HBV), of which 29 were female. The average age was 46.2 years. Regarding the type of IBD, twenty-four patients had Crohn’s disease and the duration of inflammatory bowel disease was 74 months. Fifteen patients were on concomitant immunosuppressive therapy. The effective response rate to HBV vaccine was 72.2%, verified by anti-HBs titration ≥10 UI/L. Statistical analysis revealed a negative response to vaccination in patients with Crohn’s disease and immunosuppressive drugs. CONCLUSION: The success rate of HBV immunization in IBD patients is low compared to the general population. Type of disease and use of immunosuppressive drugs appear to influence the vaccine response.info:eu-repo/semantics/openAccessInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. Arquivos de Gastroenterologia v.57 n.1 20202020-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032020000100069en10.1590/s0004-2803.202000000-12
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author CUNHA,Isabella de Souza
SILVA,Tayná Cristina da
MALLUTA,Éverson Fernando
SCOLARO,Bruno Lorenzo
VELHO,Pablo Sebastian
STALL,Juliane
spellingShingle CUNHA,Isabella de Souza
SILVA,Tayná Cristina da
MALLUTA,Éverson Fernando
SCOLARO,Bruno Lorenzo
VELHO,Pablo Sebastian
STALL,Juliane
SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
author_facet CUNHA,Isabella de Souza
SILVA,Tayná Cristina da
MALLUTA,Éverson Fernando
SCOLARO,Bruno Lorenzo
VELHO,Pablo Sebastian
STALL,Juliane
author_sort CUNHA,Isabella de Souza
title SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
title_short SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
title_full SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
title_fullStr SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
title_full_unstemmed SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
title_sort seroconversion analysis after habitual hepatitis b vaccination scheme in patients with inflammatory bowel diseases
description ABSTRACT BACKGROUND: Patients with inflammatory bowel disease (IBD) vaccinated for hepatitis B have a low success rate in achieving protective antibody levels. The main factors suggested for this are IBD itself and the use of immunosuppressive drugs. OBJECTIVE: To evaluate the concentration of anti-HBs antibodies and to verify factors associated with the effectiveness of hepatitis B vaccination in patients with IBD. METHODS: This is a prospective, consecutive, observational, descriptive and analytical, non-randomized, qualitative study that evaluated the levels of anti-HBs antibodies in IBD patients at the Interdisciplinary Inflammatory Bowel Disease Clinic of the Family and Community Health Unit of UNIVALI - Itajaí, Santa Catarina. RESULTS: Thirty-six patients were vaccinated against hepatitis B virus (HBV), of which 29 were female. The average age was 46.2 years. Regarding the type of IBD, twenty-four patients had Crohn’s disease and the duration of inflammatory bowel disease was 74 months. Fifteen patients were on concomitant immunosuppressive therapy. The effective response rate to HBV vaccine was 72.2%, verified by anti-HBs titration ≥10 UI/L. Statistical analysis revealed a negative response to vaccination in patients with Crohn’s disease and immunosuppressive drugs. CONCLUSION: The success rate of HBV immunization in IBD patients is low compared to the general population. Type of disease and use of immunosuppressive drugs appear to influence the vaccine response.
publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE.
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032020000100069
work_keys_str_mv AT cunhaisabelladesouza seroconversionanalysisafterhabitualhepatitisbvaccinationschemeinpatientswithinflammatoryboweldiseases
AT silvataynacristinada seroconversionanalysisafterhabitualhepatitisbvaccinationschemeinpatientswithinflammatoryboweldiseases
AT mallutaeversonfernando seroconversionanalysisafterhabitualhepatitisbvaccinationschemeinpatientswithinflammatoryboweldiseases
AT scolarobrunolorenzo seroconversionanalysisafterhabitualhepatitisbvaccinationschemeinpatientswithinflammatoryboweldiseases
AT velhopablosebastian seroconversionanalysisafterhabitualhepatitisbvaccinationschemeinpatientswithinflammatoryboweldiseases
AT stalljuliane seroconversionanalysisafterhabitualhepatitisbvaccinationschemeinpatientswithinflammatoryboweldiseases
_version_ 1756373583144157184